Cantor Fitzgerald Initiates Coverage On Selecta Biosciences with Overweight Rating, Announces $10 Price Target

Cantor Fitzgerald analyst Eliana Merle initiates coverage on Selecta Biosciences (NASDAQ:SELB) with a Overweight rating and a $10 price target.

Benzinga · 01/29/2020 13:17

Cantor Fitzgerald analyst Eliana Merle initiates coverage on Selecta Biosciences (NASDAQ:SELB) with a Overweight rating and a $10 price target.